AR033517A1
(es)
*
|
2000-04-08 |
2003-12-26 |
Astrazeneca Ab |
Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
|
DE60209736T2
(de)
|
2001-07-02 |
2006-11-02 |
Astrazeneca Ab |
Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen
|
GB0120461D0
(en)
|
2001-08-22 |
2001-10-17 |
Astrazeneca Ab |
Novel compounds
|
AR036366A1
(es)
|
2001-08-29 |
2004-09-01 |
Schering Corp |
Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
|
GB0122503D0
(en)
|
2001-09-18 |
2001-11-07 |
Astrazeneca Ab |
Chemical compounds
|
GB0124020D0
(en)
|
2001-10-05 |
2001-11-28 |
Astrazeneca Ab |
Chemical compounds
|
EP2243776A1
(en)
*
|
2001-10-12 |
2010-10-27 |
High Point Pharmaceuticals, LLC |
Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
|
WO2003037271A2
(en)
*
|
2001-10-30 |
2003-05-08 |
Millennium Pharmaceuticals,Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
AU2003209204A1
(en)
*
|
2002-01-10 |
2003-07-30 |
University Of Washington |
Hydrogels formed by non-covalent linkages
|
TW200303304A
(en)
|
2002-02-18 |
2003-09-01 |
Astrazeneca Ab |
Chemical compounds
|
US7183276B2
(en)
|
2002-02-28 |
2007-02-27 |
Takeda Pharmaceutical Company Limited |
Azole compounds
|
SE0200844D0
(sv)
|
2002-03-19 |
2002-03-19 |
Astrazeneca Ab |
Chemical compounds
|
SE0200843D0
(sv)
|
2002-03-19 |
2002-03-19 |
Astrazeneca Ab |
Chemical compounds
|
SE0202838D0
(sv)
*
|
2002-09-24 |
2002-09-24 |
Astrazeneca Ab |
Chemical compounds
|
EP1571146A4
(en)
*
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
|
WO2004065379A1
(en)
*
|
2003-01-17 |
2004-08-05 |
Warner-Lambert Company Llc |
Androgen receptor antagonists
|
US20040192738A1
(en)
*
|
2003-03-18 |
2004-09-30 |
Aventis Pharma Deutschland Gmbh |
2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
|
SE0300850D0
(sv)
*
|
2003-03-25 |
2003-03-25 |
Astrazeneca Ab |
Chemical compounds
|
SE0300957D0
(sv)
*
|
2003-04-01 |
2003-04-01 |
Astrazeneca Ab |
Chemical compounds
|
JPWO2004092136A1
(ja)
*
|
2003-04-18 |
2006-07-06 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその用途
|
SE0301368D0
(sv)
*
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
US20050020605A1
(en)
*
|
2003-06-13 |
2005-01-27 |
Schering Aktiengesellschaft |
Quinolyl amide derivatives as CCR-5 antagonists
|
US20070021404A1
(en)
*
|
2003-06-24 |
2007-01-25 |
Dan Peters |
Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
WO2005007644A1
(ja)
*
|
2003-06-27 |
2005-01-27 |
Banyu Pharmaceutical Co., Ltd |
ヘテロアリールオキシ含窒素飽和へテロ環誘導体
|
CA2532800C
(en)
|
2003-07-23 |
2013-06-18 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
GB0325956D0
(en)
*
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
SE0302956D0
(sv)
*
|
2003-11-07 |
2003-11-07 |
Astrazeneca Ab |
Chemical compounds
|
SE0400208D0
(sv)
|
2004-02-02 |
2004-02-02 |
Astrazeneca Ab |
Chemical compounds
|
DE602005013931D1
(ja)
*
|
2004-02-05 |
2009-05-28 |
Schering Corp |
|
SE0400925D0
(sv)
*
|
2004-04-06 |
2004-04-06 |
Astrazeneca Ab |
Chemical compounds
|
EP1753421B1
(en)
*
|
2004-04-20 |
2012-08-01 |
Amgen Inc. |
Arylsulfonamides and uses as hydroxysteroid dehydrogenase
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
KR100896546B1
(ko)
*
|
2004-08-10 |
2009-05-07 |
노파르티스 아게 |
Ccr3 억제 활성을 갖는 피페라진 유도체
|
GB0417804D0
(en)
*
|
2004-08-10 |
2004-09-15 |
Novartis Ag |
Organic compounds
|
GB0510143D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
EP1831164A1
(en)
*
|
2004-12-24 |
2007-09-12 |
AstraZeneca AB |
Heterocyclic compounds as ccr2b antagonists
|
RU2007134260A
(ru)
*
|
2005-02-16 |
2009-03-27 |
Шеринг Корпорейшн (US) |
Пиразинилзамещенные пиперазин-пиперидины с антагонистической активностью в отношении cxcr3
|
WO2006091534A1
(en)
*
|
2005-02-23 |
2006-08-31 |
Schering Corporation |
Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
|
KR20070107085A
(ko)
*
|
2005-02-23 |
2007-11-06 |
쉐링 코포레이션 |
케모카인 수용체의 억제제로서 유용한 피페리디닐 피페라진유도체
|
GB0510141D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
TW200722419A
(en)
*
|
2005-05-27 |
2007-06-16 |
Astrazeneca Ab |
Chemical compounds
|
US20080200505A1
(en)
*
|
2005-05-27 |
2008-08-21 |
Astrazeneca Ab |
Piperidines for the Treatment of Chemokine Mediated Diseases
|
PT1899322E
(pt)
|
2005-06-28 |
2009-11-09 |
Sanofi Aventis |
Derivados de isoquinolina como inibidores de rho-cinase
|
EP2402316A1
(en)
|
2005-07-21 |
2012-01-04 |
AstraZeneca AB (Publ) |
Piperidine derivatives
|
ATE521595T1
(de)
|
2005-07-26 |
2011-09-15 |
Sanofi Sa |
Cyclohexylaminisochinolonderivate als rho-kinase- inhibitor
|
NI200800025A
(es)
|
2005-07-26 |
2009-03-03 |
|
Derivados de isoquinolona sustituidos con piperidinilo en calidad de inhibidores de rho-quinasa
|
BRPI0617165B1
(pt)
|
2005-10-07 |
2023-10-03 |
Exelixis Inc |
Compostos inibidores mek, composições farmacêuticas que os contem e métodos de uso dos mesmos
|
US7576106B2
(en)
*
|
2005-10-11 |
2009-08-18 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
WO2007076318A2
(en)
*
|
2005-12-21 |
2007-07-05 |
Smithkline Beecham Corporation |
Camphor-derived cxcr3 antagonists
|
US7645773B2
(en)
|
2006-01-18 |
2010-01-12 |
Hoffmann-La Roche Inc. |
Thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase
|
EP2059515A2
(en)
*
|
2006-04-12 |
2009-05-20 |
Pfizer Limited |
Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
|
US8649933B2
(en)
|
2006-11-07 |
2014-02-11 |
Smartdrive Systems Inc. |
Power management systems for automotive video event recorders
|
CN101534824A
(zh)
*
|
2006-11-17 |
2009-09-16 |
艾博特公司 |
作为化学活素受体拮抗剂的氨基吡咯烷
|
CA2671982C
(en)
|
2006-12-14 |
2016-01-26 |
Exelixis, Inc. |
Methods of using mek inhibitors
|
CA2673920C
(en)
|
2006-12-27 |
2015-03-24 |
Sanofi-Aventis |
Cycloalkylamine substituted isoquinoline derivatives
|
SI2102164T1
(sl)
|
2006-12-27 |
2011-03-31 |
Sanofi Aventis |
Izokinolinski in izokinolinonski derivati, substituirani s cikloalkilaminom
|
AU2007338408B2
(en)
|
2006-12-27 |
2012-07-26 |
Sanofi-Aventis |
Substituted isoquinoline and isoquinolinone derivatives
|
MX2009005825A
(es)
|
2006-12-27 |
2009-06-16 |
Sanofi Aventis |
Derivados de isoquinolina e isoquinolinona sustituidos en calidad de inhibidores de rho-quinasa.
|
JP5405314B2
(ja)
|
2006-12-27 |
2014-02-05 |
サノフイ |
シクロアルキルアミン置換イソキノロン誘導体
|
CN101573354B
(zh)
|
2006-12-27 |
2014-02-12 |
塞诺菲-安万特股份有限公司 |
取代的异喹啉类及其作为Rho-激酶抑制剂的用途
|
JPWO2008108309A1
(ja)
*
|
2007-03-02 |
2010-06-17 |
協和発酵キリン株式会社 |
縮環ピリジン誘導体
|
JP2010527915A
(ja)
*
|
2007-04-26 |
2010-08-19 |
アバロン ファーマシューティカルズ,インコーポレイテッド |
多重環化合物及びその用途
|
CN101687844B
(zh)
*
|
2007-07-02 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr2受体拮抗剂的咪唑衍生物
|
KR20100050570A
(ko)
|
2007-10-01 |
2010-05-13 |
에프. 호프만-라 로슈 아게 |
Ccr 수용체 길항제로서의 n-헤테로사이클릭 바이아릴 카복스아마이드
|
MX2010013974A
(es)
|
2008-06-24 |
2011-01-14 |
Sanofi Aventis |
Isoquinolinas e isoquinolinonas 6-sustituidas.
|
DK2303845T3
(da)
|
2008-06-24 |
2013-12-16 |
Sanofi Sa |
Bi- og polycyklisk substitueret isoquinolin og bi- og polycykliske substituerede isoquinolinderivater som rho-kinasehæmmere
|
RU2538588C2
(ru)
|
2008-06-24 |
2015-01-10 |
Санофи-Авентис |
ЗАМЕЩЕННЫЕ ИЗИХИНОЛИНЫ И ИЗОХИНОЛИНОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ
|
HUP0800478A2
(en)
*
|
2008-07-31 |
2010-03-01 |
Sanofi Aventis |
Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
|
ES2775000T3
(es)
*
|
2009-04-02 |
2020-07-23 |
Merck Patent Gmbh |
Derivados de piperidina y piperazina como inhibidores de autotaxina
|
US8278302B2
(en)
*
|
2009-04-08 |
2012-10-02 |
Boehringer Ingelheim International Gmbh |
Substituted piperidines as CCR3 antagonists
|
US8435977B2
(en)
|
2009-04-22 |
2013-05-07 |
Janssen Pharmaceutica, Nv |
Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
|
BRPI1014284A2
(pt)
|
2009-04-22 |
2017-10-10 |
Janssen Pharmaceutica Nv |
azetidinil diamidas como inibidores da monoacilglicerol lipase
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
UY32940A
(es)
|
2009-10-27 |
2011-05-31 |
Bayer Cropscience Ag |
Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
|
US8356975B2
(en)
*
|
2010-03-23 |
2013-01-22 |
United Technologies Corporation |
Gas turbine engine with non-axisymmetric surface contoured vane platform
|
BR112013005141A2
(pt)
|
2010-09-03 |
2016-05-10 |
Janssen Pharmaceutica Nv |
diazetidinil diamida como inibidores de monoacilglicerol lipase
|
CA2810077A1
(en)
|
2010-09-27 |
2012-04-05 |
Peter J. Connolly |
Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
|
KR20130140020A
(ko)
|
2010-10-22 |
2013-12-23 |
얀센 파마슈티카 엔.브이. |
모노아실글리세롤 리파아제 억제제로서의 아미노-피롤리딘-아제티딘 다이아미드
|
US8513423B2
(en)
|
2010-10-22 |
2013-08-20 |
Janssen Pharmaceutica, Nv |
Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
|
GEP201706690B
(en)
|
2012-10-12 |
2017-06-26 |
Exelixis Inc |
Novel process for making compounds for use in treatment of cancer
|
AU2014318821B2
(en)
|
2013-09-10 |
2018-04-19 |
Board Of Regents Of The University Of Texas System |
Therapeutics targeting truncated Adenomatous Polyposis Coli (APC) proteins
|
WO2018112843A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
|